Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream while Breastfeeding
For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream and its risk associated with lactation. We will also discuss the usage of Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream and some common side effects associated with Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream.

What is Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream ?


How to Use: Apply an appropriate amount to the skin evenly.

Brief: Sunscreen

Can I use Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream while breastfeeding?

Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream high risk while breastfeeding
There are total 3 active ingredients in Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream which makes it a complicated task to assess the effect of Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream on breastfeeding. Here on drlact after analyzing all 3 ingredients we have reached on conclusion that Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream is unsafe in breastfeeding. Below is our summarized analysis of Titanium dioxide, Octinoxate, Zinc cation.

Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream Breastfeeding Analsys


Zinc cation while Breastfeeding

Safe

CAS Number: 1314-13-2

It is used topically as an astringent and skin protector, very often together with small amounts of Ferric Oxide to form Calamine (see specific info). It is a product compatible with breastfeeding according to WHO Essential Medicine’s List - 2002.It is also used in dental hygiene products and cosmetics. Widely used for skin protection of the diaper area in infants. Because of the small dose used and poor absorption into plasma of most topical dermatological preparations, excretion into breastmilk in significant amount appears to be unlikely. Do not apply on the breast to prevent infant ingestion; otherwise, wash it off thoroughly with water before the next breast feed.


Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream Breastfeeding Analsys - 2


Titanium dioxide and Breastfeeding

Low Risk

Not much study has been done on effects of topical usage of Titanium Dioxide during breast feeding but as there is no finding of Titanium Dioxide passing in breast milk its unlikely to cause any health issue for infant.

Some animal studies suggest that maternal exposure to titanium dioxide nanoparticles during pregnancy and lactation alters offspring hippocampal mRNA BAX and Bcl-2 levels, induces apoptosis and decreases neurogenesis. But dosage was significantly higher than daily possible exposure to humans.

Note: Study and data for tropical use only. Inhalation concerns in powder or spray products.

Warning: Tropical usage in breast area shall be avoided to prevent the Titanium Dioxide passing orally in Infants. Titanium dioxide is possibly carcinogenic to humans. Titanium dioxide can be drastically more harmful if used as powder or spray as risk of inhalation can increase significantly.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500�1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.


What should I do if I am breastfeeding mother and I am already exposed to Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream?

We have already established that Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream is unsafe in breastfeeding and breastfeeding while using Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


My doctor has prescribed me Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream, what should I do?

If your doctor knows that you are breastfeeding mother and still prescribes Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream then there must be good reason for that as Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Provence Foundation Spf31 Pa Plus Plus No 23 | Titanium Dioxide, Octinoxate, Zinc Oxide Cream in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients